117 related articles for article (PubMed ID: 7075490)
1. [Clinical value of bronchoalveolar lavage in progressive systemic scleroderma (author's transl)].
König G; Luderschmidt C; Clocuh YP; Scherer U; Fruhmann G
Dtsch Med Wochenschr; 1982 May; 107(19):723-7. PubMed ID: 7075490
[TBL] [Abstract][Full Text] [Related]
2. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
Owens GR; Paradis IL; Gryzan S; Medsger TA; Follansbee WP; Klein HA; Dauber JH
J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
[TBL] [Abstract][Full Text] [Related]
3. [New knowledge on the diagnosis and prognosis of interstitial lung disease in scleroderma].
König G; Behr J; Luderschmidt C
Z Rheumatol; 1990; 49(5):279-83. PubMed ID: 2080684
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients.
Luzina IG; Atamas SP; Wise R; Wigley FM; Choi J; Xiao HQ; White B
Arthritis Rheum; 2003 Aug; 48(8):2262-74. PubMed ID: 12905481
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.
Kowal-Bielecka O; Kowal K; Rojewska J; Bodzenta-Lukaszyk A; Siergiejko Z; Sierakowska M; Sierakowski S
Ann Rheum Dis; 2005 Sep; 64(9):1343-6. PubMed ID: 16100339
[TBL] [Abstract][Full Text] [Related]
6. Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features.
Edelson JD; Hyland RH; Ramsden M; Chamberlain DW; Kortan P; Meindok HO; Klein MH; Braude AC; Lee P; Rebuck AS
J Rheumatol; 1985 Oct; 12(5):957-63. PubMed ID: 4087272
[TBL] [Abstract][Full Text] [Related]
7. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].
Witt C; Apostoloff E; Müller GM; Buchali K; Hiepe F; Brenke A; Romberg B; Winsel K
Pneumologie; 1992 Jan; 46(1):20-5. PubMed ID: 1312240
[TBL] [Abstract][Full Text] [Related]
8. Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid.
Silver RM; Metcalf JF; LeRoy EC
Arthritis Rheum; 1986 Apr; 29(4):525-31. PubMed ID: 3707630
[TBL] [Abstract][Full Text] [Related]
9. The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases.
Breit SN; Cairns D; Szentirmay A; Callaghan T; Murray D; Wacher T; Gibson PG; Marks G; Bryant DH; Yeates M
J Rheumatol; 1989 Aug; 16(8):1043-9. PubMed ID: 2585401
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
Bröll H; Tausch G; Eberl R
Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the bronchoalveolar lavage fluid of diffuse interstitial lung disease (hypersensitivity pneumonitis, sarcoidosis and idiopathic pulmonary fibrosis (author's transl)].
Harada S; Kajiki A; Miyazaki N; Higuchi K; Takamoto M; Ishibashi T; Shigematsu N
Nihon Kyobu Shikkan Gakkai Zasshi; 1981 Aug; 19(8):549-57. PubMed ID: 7311210
[No Abstract] [Full Text] [Related]
12. [Pulmonary involvement in sclerodermia].
Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
[TBL] [Abstract][Full Text] [Related]
13. [Lymphocytic interstitial pneumonia in Gougerot-Sjögren syndrome with scleroderma].
Allard P; Kermarec J; L'Her P; Natali F; Lebarbu M; Le Vagueresse R
Ann Med Interne (Paris); 1984; 135(6):431-4. PubMed ID: 6508046
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
[TBL] [Abstract][Full Text] [Related]
15. [Erasmus syndrome: clinical, tomographic, respiratory function and bronchoalveolar lavage characteristics].
Cointrel C; Tillie-Leblond I; Lamblin C; Furon D; Tonnel AB; Wallaert B
Rev Mal Respir; 1997 Jan; 14(1):21-6. PubMed ID: 9082502
[TBL] [Abstract][Full Text] [Related]
16. CREST syndrome: a variant of progressive systemic sclerosis, associated with interstitial pulmonary fibrosis and malignancy.
Salvant EE; Carter JM; Armstrong EM; Polk OD; Austin KI
South Med J; 1988 Sep; 81(9):1185-7. PubMed ID: 3420453
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage in the cytologic diagnosis of carcinoma of the lung.
Linder J; Radio SJ; Robbins RA; Ghafouri M; Rennard SI
Acta Cytol; 1987; 31(6):796-801. PubMed ID: 3425141
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer and scleroderma.
Winkelmann RK; Flach DB; Unni KK
Arch Dermatol Res; 1988; 280 Suppl():S15-8. PubMed ID: 2841907
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
Várai G; Earle L; Jimenez SA; Steiner RM; Varga J
J Rheumatol; 1998 Jul; 25(7):1325-9. PubMed ID: 9676764
[TBL] [Abstract][Full Text] [Related]
20. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
